Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Patient sample, cell culture, mouse and rat studies suggest inhibiting ENO1 could help
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury